Skip to Content

Thea Helm Wiken

Thea Helm Wiken, MD, is a PhD-student working at the Department of Gastroenterology at Oslo University Hospital (OUH) in Norway. She is doing a project on switching inflammatory bowel disease patients from intravenous to subcutaneous vedolizumab maintenance treatment. Her ongoing research also includes comparing effect of vedolizumab and ustekinumab in patients with Ulcerative Colitis.


Back to top